Form4insider filings, from the source

SEC Form 4 · accession 0000921895-17-001061

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
Apr 11, 2017
Accepted (ET)
Apr 14, 2017 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1holding———20,227D
Common StockF1,F2holding———1,666,755IBy: Lone Star Value Investors, LP
9.00% Series A Cumulative Preferred StockF2holding———363,611IBy: Lone Star Value Investors, LP
Common StockF1,F3holding———83,108IBy: Separately Managed Account

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitF4,F5—Apr 11, 2017A10,522A——Common Stock10,52210,522D
Restricted Stock UnitF4,F6—Apr 11, 2017A9,985A——Common Stock9,9859,985D

Explanation of responses